Page 50 - JCBP-3-3
P. 50

Journal of Clinical and
            Basic Psychosomatics                                                  Microbiota in psychosomatic disorders



               doi: 10.1001/jamapsychiatry.2021.2573              medicine perspective. Indian J Microbiol. 2022;62(4):505‑515.
            124.  Fukui H, Nishida A, Matsuda S, et al. Usefulness of machine      doi: 10.1007/s12088‑022‑01033‑w
               learning-based gut microbiome analysis for identifying patients
               with irritable bowels syndrome. J Clin Med. 2020;9(8):2403.  134. Simon MC, Sina C, Ferrario PG, Daniel H, Working Group
                                                                  “Personalized Nutrition” of the German Nutrition Society.
               doi: 10.3390/jcm9082403                            Gut  microbiome  analysis  for  personalized  nutrition:  The
            125. Kolobaric A, Andreescu C, Jašarević E, et al. Gut microbiome   state of science. Mol Nutr Food Res. 2023;67(1):2200476.
               predicts cognitive function and depressive symptoms in late      doi: 10.1002/mnfr.202200476
               life. Mol Psychiatry. 2024;29(10):3064‑3075.
                                                               135.  Dicks  LM.  Gut  bacteria  and  neurotransmitters.
               doi: 10.1038/s41380‑024‑02551‑3                    Microorganisms. 2022;10(9):1838.
            126. Elgellaie A, Thomas SJ, Kaelle J, Bartschi J, Larkin T.      doi: 10.3390/microorganisms10091838
               Pro‐inflammatory cytokines IL‐1α, IL‐6 and TNF‐α
               in  major  depressive  disorder:  Sex‐specific  associations   136. Barrea L, Muscogiuri G, Frias-Toral E, et al. Nutrition and
               with psychological symptoms.  Eur J Neurosci.      immune  system:  From  the  Mediterranean  diet  to  dietary
               2023;57(11):1913‑1928.                             supplementary through the microbiota. Crit Rev Food Sci
                                                                  Nutr. 2021;61(18):3066‑3090.
               doi: 10.1111/ejn.15992
                                                                  doi: 10.1080/10408398.2020.1792826
            127.  Fogelson KA, Dorrestein PC, Zarrinpar A, Knight R. The gut
               microbial bile acid modulation and its relevance to digestive   137. Rawat K, Singh N, Kumari P, Saha L. A review on preventive
               health and diseases. Gastroenterology. 2023;164(7):1069‑1085.  role of ketogenic diet (KD) in CNS disorders from the gut
                                                                  microbiota perspective. Rev Neurosci. 2021;32(2):143‑157.
               doi: 10.1053/j.gastro.2023.02.022
                                                                  doi: 10.1515/revneuro‑2020‑0078
            128. Averina OV, Poluektova EU, Marsova MV, Danilenko VN.
               Biomarkers and utility of the antioxidant potential of probiotic   138. Geng P, Zhao N, Zhou Y, Harris RS, Ge Y. Faecalibacterium
               Lactobacilli  and bifidobacteria  as representatives  of the   prausnitzii regulates carbohydrate metabolic functions
               human gut microbiota. Biomedicines. 2021;9(10):1340.  of  the  gut  microbiome  in  C57BL/6  mice.  Gut Microbes.
                                                                  2025;17(1):2455503.
               doi: 10.3390/biomedicines9101340
                                                                  doi: 10.1080/19490976.2025.2455503
            129.  Rábago-Monzón ÁR, Rodríguez-Rosas AM, Baldenebro-
               Félix  DL,  et al. Influence of the intestinal microbiome   139. Shukla V, Singh S, Verma S, Verma S, Rizvi AA, Abbas M.
               associated with the development of neurodegenerative   Targeting the microbiome to improve human health with
               diseases: Literature review. Rev Med UAS. 2024;14(2):171‑181.  the approach of personalized medicine: Latest aspects and
               doi: 10.28960/revmeduas.2007‑8013.v14.n2.008       current updates. Clin Nutr ESPEN. 2024;63:813‑820.
            130. He X, Zhao S, Li Y. Faecalibacterium prausnitzii: A Next‐     doi: 10.1016/j.clnesp.2024.08.005
               generation  probiotic  in  gut  disease  improvement.  Can J   140.  Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota
               Infect Dis Med Microbiol. 2021;2021(1):6666114.    transplantation for  Clostridioides difficile:  Mechanisms  and
               doi: 10.1155/2021/6666114                          pharmacology. Nat Rev Gastroenterol Hepatol. 2021;18(1):67‑80.
            131. Cheng Y, Liu J, Ling Z. Short-chain fatty acids-producing      doi: 10.1038/s41575‑020‑0350‑4
               probiotics: A novel source of psychobiotics. Crit Rev Food   141. Effendi RM, Anshory M, Kalim H,  et al.  Akkermansia
               Sci Nutr. 2022;62(28):7929‑7959.                   muciniphila  and  Faecalibacterium prausnitzii  in  immune-
               doi: 10.1080/10408398.2021.1920884                 related diseases. Microorganisms. 2022;10(12):2382.
            132. Yoo S, Jung SC, Kwak K, Kim JS. The role of prebiotics in      doi: 10.3390/microorganisms10122382
               modulating gut microbiota: Implications for human health.   142. Cani PD, Depommier C, Derrien M, Everard A, de Vos WM.
               Int J Mol Sci. 2024;25(9):4834.                    Akkermansia muciniphila:  Paradigm  for  next‑generation
               doi: 10.3390/ijms25094834                          beneficial microorganisms. Nat Rev Gastroenterol Hepatol.
                                                                  2022;19(10):625‑637.
            133. Chunduri A, Reddy SD, Jahanavi M, Reddy CN. Gut-brain
               axis, neurodegeneration and mental health: A personalized      doi: 10.1038/s41575‑022‑00631‑9










            Volume 3 Issue 3 (2025)                         44                         doi: 10.36922/JCBP025040008
   45   46   47   48   49   50   51   52   53   54   55